Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23565884 | 0.94 | KDM4E (0.32) | KDM4EMAPK1ATMSETD7 | |
| SCHEMBL23565877 | 0.92 | KDM4E (0.34) | KDM4EMAPK1ATMSETD7MAOA | |
| SCHEMBL23565765 | 0.87 | — | — | |
| SCHEMBL23919877 | 0.86 | — | — | |
| SCHEMBL23919939 | 0.85 | KDM4E (0.31) | KDM4ESETD7 | |
| SCHEMBL23565730 | 0.84 | KDM4E (0.30) | KDM4EMAPK1ATM | |
| SCHEMBL23919567 | 0.84 | — | — | |
| SCHEMBL23920063 | 0.84 | HRH4 (0.33) | — | |
| SCHEMBL23339963 | 0.81 | KDM4E (0.36) | KDM4EMAPK1ATMSETD7 | |
| SCHEMBL23919920 | 0.79 | SETD7 (0.32) | KDM4EMAPK1ATMSETD7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-01-12 | — | — | US | disclosed |
| EP-3892704-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
| WO-2021126593-A1 | ELECTROACTIVE COMPOUNDS | DUPONT ELECTRONICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | NR4A2, NR2C2, ESR2 | KDM4E 1566/4885MAPK1 1776/4885ATM 3794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.